Profile for European Patent Office Patent: 2119715
✉ Email this page to a colleague
| Country | SPC | SPC Expiration |
|---|---|---|
| Netherlands | 300802 | ⤷ Start Trial |
| Ireland | 2018/006 | ⤷ Start Trial |
US Patent Family Members and Approved Drugs for European Patent Office Patent: 2119715
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
